Showing results (81-90 of 895) with videos related to
Sort By:
Pageof 90
Current Opinion in Rheumatology|April 23, 2003
Plasmapheresis for rheumatic diseases in the twenty-first century: take it or leave it?Yolanda Braun-Moscovici, Daniel E FurstBiodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|October 3, 2001
Recombinant relaxin: a review of pharmacology and potential therapeutic useE S Gavino, D E FurstSeminars in Arthritis and Rheumatism|August 1, 1991
The efficacy and safety of low-dose corticosteroids for rheumatoid arthritisJ R Caldwell, D E FurstBailliere'S Clinical Rheumatology|April 1, 1989
Environmentally-induced systemic sclerosis-like illnessN R Straniero, D E FurstAmerican Journal of Surgery|February 12, 2000
The role of the gastrointestinal tract in postinjury multiple organ failureF A MooreExpert Opinion on Drug Metabolism & Toxicology|July 26, 2006
Meloxicam in rheumatoid arthritisMansoor Ahmed, Dinesh Khanna, Daniel E FurstLancet (London, England)|May 23, 2006
Systemic sclerosis: hypothesis-driven treatment strategiesChristina Charles, Philip Clements, Daniel E FurstCurrent Rheumatology Reports|December 21, 2000
Bone marrow transplantation in the treatment of systemic sclerosisF Viganego, R Nash, D E FurstDrug Safety|April 6, 2004
Safety of tumour necrosis factor-alpha antagonistsDinesh Khanna, Maureen McMahon, Daniel E FurstExpert Opinion on Biological Therapy|May 20, 2015
Brodalumab -an IL-17RA monoclonal antibody for psoriasis and psoriatic arthritisErin Bauer, Jessica Lucier, Daniel E FurstPageof 90